Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

964 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT.
Murata M, Ikegame K, Morishita Y, Ogawa H, Kaida K, Nakamae H, Ikeda T, Nishida T, Inoue M, Eto T, Kubo K, Sakura T, Mori T, Uchida N, Ashida T, Matsuhashi Y, Miyazaki Y, Ichinohe T, Atsuta Y, Teshima T. Murata M, et al. Among authors: eto t. Bone Marrow Transplant. 2017 Feb;52(2):252-257. doi: 10.1038/bmt.2016.247. Epub 2016 Nov 21. Bone Marrow Transplant. 2017. PMID: 27869808 Clinical Trial.
Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR.
Imahashi N, Suzuki R, Fukuda T, Kakihana K, Kanamori H, Eto T, Mori T, Kobayashi N, Iwato K, Sakura T, Ikegame K, Kurokawa M, Kondo T, Iida H, Sakamaki H, Tanaka J, Kawa K, Morishima Y, Atsuta Y, Miyamura K. Imahashi N, et al. Among authors: eto t. Bone Marrow Transplant. 2013 Jan;48(1):56-62. doi: 10.1038/bmt.2012.84. Epub 2012 Jun 18. Bone Marrow Transplant. 2013. PMID: 22705800
Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry.
Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H, Taniguchi S, Miyamura K, Takahashi S, Eto T, Ogawa H, Kurokawa M, Tanaka J, Kawa K, Kato K, Suzuki R, Morishima Y, Sakamaki H, Fukuda T. Kurosawa S, et al. Among authors: eto t. Bone Marrow Transplant. 2013 Apr;48(4):529-36. doi: 10.1038/bmt.2012.172. Epub 2012 Sep 10. Bone Marrow Transplant. 2013. PMID: 22964595 Clinical Trial.
Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia.
Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H, Taniguchi S, Miyamura K, Takahashi S, Eto T, Ogawa H, Kurokawa M, Tanaka J, Kawa K, Kato K, Suzuki R, Morishima Y, Sakamaki H, Fukuda T. Kurosawa S, et al. Among authors: eto t. Bone Marrow Transplant. 2013 Sep;48(9):1198-204. doi: 10.1038/bmt.2013.42. Epub 2013 Apr 8. Bone Marrow Transplant. 2013. PMID: 23562971
Risk factors and organ involvement of chronic GVHD in Japan.
Kanda J, Nakasone H, Atsuta Y, Toubai T, Yokoyama H, Fukuda T, Taniguchi S, Ohashi K, Ogawa H, Eto T, Miyamura K, Morishima Y, Nagamura-Inoue T, Sakamaki H, Murata M. Kanda J, et al. Among authors: eto t. Bone Marrow Transplant. 2014 Feb;49(2):228-35. doi: 10.1038/bmt.2013.151. Epub 2013 Sep 30. Bone Marrow Transplant. 2014. PMID: 24076549
Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation.
Nakasone H, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T, Miyamura K, Eto T, Kanamori H, Iwato K, Uchida N, Mori S, Nagamura-Inoue T, Ichinohe T, Atsuta Y, Teshima T, Murata M; GVHD working group of the Japan Society of Hematopoietic Cell Transplantation. Nakasone H, et al. Among authors: eto t. Bone Marrow Transplant. 2015 Apr;50(4):559-65. doi: 10.1038/bmt.2014.293. Epub 2014 Dec 22. Bone Marrow Transplant. 2015. PMID: 25531281 Clinical Trial.
Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation.
Arai Y, Kanda J, Nakasone H, Kondo T, Uchida N, Fukuda T, Ohashi K, Kaida K, Iwato K, Eto T, Kanda Y, Nakamae H, Nagamura-Inoue T, Morishima Y, Hirokawa M, Atsuta Y, Murata M; GVHD working group of the Japan Society for Hematopoietic Cell Transplantation. Arai Y, et al. Among authors: eto t. Bone Marrow Transplant. 2016 Jan;51(1):96-102. doi: 10.1038/bmt.2015.205. Epub 2015 Sep 14. Bone Marrow Transplant. 2016. PMID: 26367230 Clinical Trial.
Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the adult ALL WG of the JSHCT.
Nishiwaki S, Imai K, Mizuta S, Kanamori H, Ohashi K, Fukuda T, Onishi Y, Takahashi S, Uchida N, Eto T, Nakamae H, Yujiri T, Mori S, Nagamura-Inoue T, Suzuki R, Atsuta Y, Tanaka J. Nishiwaki S, et al. Among authors: eto t. Bone Marrow Transplant. 2016 Jan;51(1):43-50. doi: 10.1038/bmt.2015.217. Epub 2015 Sep 21. Bone Marrow Transplant. 2016. PMID: 26389833 Clinical Trial.
Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma.
Fuji S, Fujiwara H, Nakano N, Wake A, Inoue Y, Fukuda T, Hidaka M, Moriuchi Y, Miyamoto T, Uike N, Taguchi J, Eto T, Tomoyose T, Kondo T, Yamanoha A, Ichinohe T, Atsuta Y, Utsunomiya A; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation. Fuji S, et al. Among authors: eto t. Bone Marrow Transplant. 2016 Feb;51(2):205-11. doi: 10.1038/bmt.2015.265. Epub 2015 Nov 2. Bone Marrow Transplant. 2016. PMID: 26524263 Clinical Trial.
964 results